Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 1Precancerous Gastric Lesions 1Neutropenia 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Fever 1Familial primary gastric lymphoma 1Atrophy 1

Interventions

liposomal amphotericin B 2Vancomycin 2Cefepime 2trametinib 1pegfilgrastim 1dabrafenib 1ceftobiprole medocaril 1Tazobactam 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Levofloxacin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Filgrastim 1Ciprofloxacin 1Caspofungin 1Bevacizumab 1Anti-Bacterial Agents 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Fever × Amoxicillin × Clear all
NCT00107081 2020-11-02

Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting

Swiss Pediatric Oncology Group

Phase 3 Terminated
70 enrolled

Fever, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡